Bell Investment Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bell Investment Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-41	Closed	-$2.85K	–	1965
2024 Q3	$2.85K	Hold	41	–	–	﹤0.01%	1207
2024 Q2	$2.76K	Hold	41	–	–	﹤0.01%	1218
2024 Q1	$2.83K	Hold	41	–	–	﹤0.01%	1201
2023 Q4	$2.55K	Buy	41 +12	+41%	+$671	﹤0.01%	1223
2023 Q3	$1.63K	Sell	29 -12	-29%	-$675	﹤0.01%	1376
2023 Q2	$2.07K	Buy	41 +10	+32%	+$532	﹤0.01%	1280
2023 Q1	$1.69K	Sell	31 -6	-16%	-$351	﹤0.01%	1345
2022 Q4	$2.31K	Sell	37 -12	-24%	-$796	﹤0.01%	1210
2022 Q3	$3K	Buy	49 +27	+123%	+$1.86K	﹤0.01%	1006
2022 Q2	$1K	Buy	+22	New	+$1.21K	﹤0.01%	1677

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bell Investment Advisors's AXNX Position: Q4 2024 in Review

Bell Investment Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 41 shares — an estimated $2.85K sold.

Bell Investment Advisors first reported a position in AXNX in Q2 2022 and held it in 10 quarters. The position peaked at $3K in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Bell Investment Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Bell Investment Advisors sold 41 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $2.85K.
Bell Investment Advisors first reported a position in Axonics, Inc. Common Stock in Q2 2022 and held it in 10 quarters.
Bell Investment Advisors's Axonics, Inc. Common Stock position peaked at $3K in Q3 2022.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Bell Investment Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.